“Bioethics of Intervention and the Case of Drugs Bevacizumab and Ranibizumab for Retinal Diseases”. 2016. Revista Iberoamericana De Bioética, no. 2 (October): 1-10. https://doi.org/10.14422/rib.i02.y2016.004.